REDUCED MORTALITY RATES WITH ANTI-TUMOR NECROSIS FACTOR ALPHA DIRECTED THERAPY WHEN COMPARED TO PROLONGED CORTICOSTEROID THERAPY FOR INFLAMMATORY BOWEL DISEASE

被引：2
|
作者：
Lewis, James D.
Scott, Frank I.
Brensinger, Colleen M.
Roy, Jason A.
Osterman, Mark T.
Mamtani, Ronac
Chen, Lang
Yun, Huifeng
Xie, Fenglong
Curtis, Jeffrey R.
机构：
来源：
GASTROENTEROLOGY | 2017年 / 152卷 / 05期
关键词：
D O I：
10.1016/S0016-5085(17)30570-X
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
247
引用
收藏
页码：S64 / S65
页数：2
相关论文
共 50 条
  • [1] Increased Mortality Rates With Prolonged Corticosteroid Therapy When Compared With Antitumor Necrosis Factor-α-Directed Therapy for Inflammatory Bowel Disease
    Lewis, James D.
    Scott, Frank I.
    Brensinger, Colleen M.
    Roy, Jason A.
    Osterman, Mark T.
    Mamtani, Ronac
    Bewtra, Meenakshi
    Chen, Lang
    Yun, Huifeng
    Xie, Fenglong
    Curtis, Jeffrey R.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 (03): : 405 - 417
  • [2] Safety of anti-tumor necrosis factor therapy in inflammatory bowel disease
    Frank Hoentjen
    Ad A van Bodegraven
    World Journal of Gastroenterology, 2009, 15 (17) : 2067 - 2073
  • [3] Safety of anti-tumor necrosis factor therapy in inflammatory bowel disease
    Hoentjen, Frank
    Van Bodegraven, Ad A.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (17) : 2067 - 2073
  • [4] Association of Anti-Tumor Necrosis Factor Therapy With Mortality Among Veterans With Inflammatory Bowel Disease
    Cohen-Mekelburg, Shirley
    Wallace, Beth I.
    Van, Tony
    Wiitala, Wyndy L.
    Govani, Shail M.
    Burns, Jennifer
    Lipson, Rachel
    Yun, Huifeng
    Hou, Jason
    Lewis, James D.
    Dominitz, Jason A.
    Waljee, Akbar K.
    JAMA NETWORK OPEN, 2021, 4 (03)
  • [5] Anti-Tumor Necrosis Factor Alpha Antibodies for Remission Maintenance Therapy in Inflammatory Bowel Disease
    Neubauer, Katarzyna
    Kempinski, Radoslaw
    Poniewierka, Elzbieta
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2010, 19 (02): : 143 - 149
  • [6] Psoriasis Associated With Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease
    Cullen, Garret
    Kroshinsky, Daniela
    Cheifetz, Adam S.
    Korzenik, Joshua R.
    GASTROENTEROLOGY, 2011, 140 (05) : S774 - S775
  • [7] Aortic Stiffness in Patients With Inflammatory Bowel Disease Reduced After Anti-Tumor Necrosis Factor Therapy
    Zanoli, Luca
    Inserra, Gaetano
    Cappello, Maria
    Ozturk, Kadir
    Castellino, Pietro
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (08) : 981 - 982
  • [8] Anti-Tumor Necrosis Factor Therapy and Risk of Kidney Function Decline and Mortality in Inflammatory Bowel Disease
    Sumida, Keiichi
    Shrestha, Prabin
    Mallisetty, Yamini
    Thomas, Fridtjof
    Gyamlani, Geeta
    Streja, Elani
    Kalantar-Zadeh, Kamyar
    Kovesdy, Csaba P.
    JAMA NETWORK OPEN, 2024, 7 (04) : E246822
  • [9] Anti-tumor necrosis factor therapy for pediatric inflammatory bowel diseases
    Bujanover, Yoram
    Weiss, Batia
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2008, 10 (8-9): : 634 - 639
  • [10] Vitamin D status and response to anti-tumor necrosis factor-alpha therapy in inflammatory bowel disease
    Bak, N. F.
    Hald, S.
    Rasch, M. B.
    Dige, A.
    Agnholt, J. S.
    Dahlerup, J. F.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S318 - S318
12345